<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To compare the frequency and type of neurological complications after bone marrow transplantation (BMT) with an HLA identical unrelated donor or a mismatched related donor (alternative donors) to the neurological complications after matched sibling BMT for standard and high risk <z:mpath ids='MPATH_336'>leukaemia</z:mpath> or <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Retrospective analysis of consecutively treated patients with (a) BMT from alternative donors (n=39), (b) treated with matched sibling BMT for standard risk <z:mpath ids='MPATH_336'>leukaemia</z:mpath>, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, or aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> (n=53), and (c) treated with matched sibling BMT for high risk <z:mpath ids='MPATH_336'>leukaemia</z:mpath>, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, or aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> (n=49) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: A total of 72 neurological complications were found </plain></SENT>
<SENT sid="3" pm="."><plain>Most of these occurred within the first 6 months after transplant </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty six patients developed a severe neurological complication: 17 Alternative donor patients (44%) by contrast with six standard risk patients (11%) and 13 high risk patients (27%; p&lt;0.005) </plain></SENT>
<SENT sid="5" pm="."><plain>The most frequent complication was a metabolic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> occurring in 18% of patients </plain></SENT>
<SENT sid="6" pm="."><plain>Most of the <z:hpo ids='HP_0001298'>encephalopathies</z:hpo> were caused by either the transplant procedure, cyclosporin, <z:e sem="disease" ids="C0243026" disease_type="Disease or Syndrome" abbrv="">systemic infections</z:e>, microangiopathic <z:e sem="disease" ids="C0865262" disease_type="Disease or Syndrome" abbrv="">thrombopathy</z:e>, or by complications induced by <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft versus host disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infections</z:e> of the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> developed in 9% of patients, cerebrovascular lesions in 3% </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Severe neurological complications are more frequent after BMT from alternative donors </plain></SENT>
<SENT sid="9" pm="."><plain>This is mainly due to increased treatment related morbidity and to more profound immunosuppression after BMT from alternative donors </plain></SENT>
</text></document>